Management Changes

Cessation as SMP

  • Ravi Kumar (Global Head – Injectables/Head of Corporate Strategy, Portfolio & SPO) resigned from his position as Senior Management Personnel
  • Effective date: Close of business hours on July 24, 2026
  • Reason for cessation: Resignation due to personal reasons
  • No relationship disclosure between directors required (not applicable)

New Designation as SMP

  • Preeti Kalra designated as Senior Management Personnel (Head - Human Resources)
  • Effective date: July 24, 2026
  • Profile: HR leader with 25+ years of experience across Biopharma, Global Development (Not-for-Profit), Public Services, Insurance, GCC and IT
  • Previous organizations include Stelis Biopharma, Biocon Biologics, Bill & Melinda Gates Foundation, Serco and Ernst & Young
  • Expertise areas: Business partnering, talent management, leadership development, organizational transformation, culture, organization effectiveness and change management
  • Geographic experience: Asia-Pacific, Middle East, Africa, Europe and North America
  • No relationship disclosure between directors required (not applicable)

Additional Documentation

  • Resignation letter from Ravi Kumar attached as Annexure 3 as required under Part A (A) (7C) of Schedule III to the Listing Regulations
  • Initial intimation regarding these changes was made on July 24, 2026

Compliance Details

  • Disclosure made pursuant to SEBI Circular No. HO/49/14/14(7)2025-CFDPOD2/I/3762/2026 dated January 30, 2026
  • Signed by A. Trisha, Company Secretary and Compliance Officer (Membership Number: A47635) on July 27, 2026